Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features

• Autors principals: Gennaro De Pascale (Autor), Gabriele Pintaudi (Autor), Lucia Lisi (Autor), Flavio De Maio (Autor), Salvatore Lucio Cutuli (Autor), Eloisa Sofia Tanzarella (Autor), Simone Carelli (Autor), Gianmarco Lombardi (Autor), Melania Cesarano (Autor), Veronica Gennenzi (Autor), Gabriella Maria Pia Ciotti (Autor), Domenico Luca Grieco (Autor), Brunella Posteraro (Autor), Maurizio Sanguinetti (Autor), Pierluigi Navarra (Autor), Massimo Antonelli (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2023-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

(1) Background: Colistin-only susceptible (COS) <i>Acinetobacter baumannii</i> (AB) ventilator-associated pneumonia (VAP) represents a clinical challenge in the Intensive Care Unit (ICU) due to the negligible lung diffusion of this molecule and the low-grade evidence on efficacy of its n...